Ramazan Idilman

Ramazan Idilman

Ankara Üniversitesi

H-index: 48

Asia-Turkey

About Ramazan Idilman

Ramazan Idilman, With an exceptional h-index of 48 and a recent h-index of 33 (since 2020), a distinguished researcher at Ankara Üniversitesi, specializes in the field of Hepatology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease

Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study

Geographic Disparities in Access to Liver Transplant for Advanced Cirrhosis: Time to Ring the Alarm!

Development Of Metabolic Disorders In Liver Transplant Recipients

TASL practice guidance on the clinical assessment and management of patients with nonalcoholic fatty liver disease

Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study

Ramazan Idilman Information

University

Ankara Üniversitesi

Position

School of Medicine

Citations(all)

11695

Citations(since 2020)

6555

Cited By

7578

hIndex(all)

48

hIndex(since 2020)

33

i10Index(all)

143

i10Index(since 2020)

82

Email

University Profile Page

Ankara Üniversitesi

Ramazan Idilman Skills & Research Interests

Hepatology

Top articles of Ramazan Idilman

Title

Journal

Author(s)

Publication Date

Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Liver International

Olympia E Anastasiou

Florin A Caruntu

Manuela G Curescu

Kendal Yalcin

Ulus S Akarca

...

2024/1

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

Journal of Hepatology

Devin Razavi-Shearer

H Child

K Razavi-Shearer

A Voeller

H Razavi

...

2024/2/1

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease

Alimentary Pharmacology & Therapeutics

Nabil Noureddin

Daniel Q Huang

Ricki Bettencourt

Harris Siddiqi

Abdul M Majzoub

...

2024/4/3

Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study

Hepatology Forum

Mesut Akarsu

Suleyman Dolu

Murat Harputluoglu

Sezai Yilmaz

Murat Akyildiz

...

2024

Geographic Disparities in Access to Liver Transplant for Advanced Cirrhosis: Time to Ring the Alarm!

American Journal of Transplantation

Jasmohan S Bajaj

Ashok Choudhury

Vinay Kumaran

Florence Wong

Wai Kay Seto

...

2024/2/21

Development Of Metabolic Disorders In Liver Transplant Recipients

Zeitschrift für Gastroenterologie

Gizem Erdemir

Hale Gökcan

Ramazan Idilman

2023/1

TASL practice guidance on the clinical assessment and management of patients with nonalcoholic fatty liver disease

Hepatology forum

Yusuf Yilmaz

Mujdat Zeybel

Gupse Adali

Arif Mansur Cosar

Elif Sertesen

...

2023

Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study

Hepatology

Beom Kyung Kim

Jaclyn Bergstrom

Rohan Loomba

Nobuharu Tamaki

Namiki Izumi

...

2023/12/1

The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort

Hepatology Forum

Serkan Yaras

Mehmet Demir

Sezgin Barutcu

Abdullah Emre Yildirim

Selim Gurel

...

2023

Management of Biliary Complications in Liver Transplant Recipients with Duct-To-Duct Anastomosis: A Single-Center Experience

The Turkish Journal of Gastroenterology

Muhammed Fatih Karakaya

Erdem Er

Onur Kırımker

Mesut Gümüşsoy

Emin Bodakçi

...

2023/2

The role of PAGE-B score in predicting the development of hepatocelular cancer in patients with chronic delta hepatitis

Journal of Hepatology

Onur Keskin

Cagdas Kalkan

Bengi Ozturk

Aysun Caliskan

Hasan Sahin

...

2023/6/1

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos (t) ide analogues for the treatment of chronic …

The Lancet Gastroenterology & Hepatology

Man-Fung Yuen

Tarik Asselah

Ira M Jacobson

Maurizia Rossana Brunetto

Harry LA Janssen

...

2023/9/1

Private insurance access is associated with higher liver transplant listing and transplant access and lower mortality compared to national insurances in a large multinational …

Jasmohan S Bajaj

Florence Wong

Qing Xie

Patrick S Kamath

Mark Topazian

...

2023

Sa1566 NATURAL HISTORY OF HEPATIC DECOMPENSATION AND LIVER-RELATED OUTCOMES IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Gastroenterology

Nabil Noureddin

Daniel Huang

Richele Bettencourt

Harris Siddiqi

Abdul Majzoub

...

2023/5/1

Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial

Liver International

Katja Dinkelborg

Julia Kahlhöfer

Petra Dörge

Cihan Yurdaydin

Svenja Hardtke

...

2023/8

Effect Of Prognostic Noninvasive Tests On Disease Outcome Of Alcohol-Related Liver Disease

Zeitschrift für Gastroenterologie

Burak Alper Zengin

Mesut Gümüşsoy

Serkan Duman

Emin Bodakçı

Zeynep Ellik

...

2023/1

Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED study

Jasmohan S Bajaj

Florence Wong

Qing Xie

Patrick S Kamath

Mark Topazian

...

2023

A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to …

European Radiology

Serkan Duman

Digdem Kuru

Mesut Gumussoy

Saba Kiremitci

Hale Gokcan

...

2023/11/21

Alcohol-related etiology is an independent predictor of inpatient mortality in patients with cirrhosis in a prospective global consortium

Ashok Kumar Choudhury

Florence Wong

Qing Xie

Patrick S Kamath

Mark Topazian

...

2023

Sa1553 HEPATIC DECOMPENSATION AND HEPATOCELLULAR CARCINOMA RISK IN NONALCOHOLIC FATTY LIVER DISEASE AMONG PATIENTS WITH DIABETES VERSUS PATIENTS WITHOUT DIABETES: SYSTEMATIC …

Daniel Huang

Nabil Noureddin

Veeral Ajmera

Maral Amangurbanova

Richele Bettencourt

...

2023/5/1

See List of Professors in Ramazan Idilman University(Ankara Üniversitesi)

Ramazan Idilman FAQs

What is Ramazan Idilman's h-index at Ankara Üniversitesi?

The h-index of Ramazan Idilman has been 33 since 2020 and 48 in total.

What are Ramazan Idilman's top articles?

The articles with the titles of

Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease

Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study

Geographic Disparities in Access to Liver Transplant for Advanced Cirrhosis: Time to Ring the Alarm!

Development Of Metabolic Disorders In Liver Transplant Recipients

TASL practice guidance on the clinical assessment and management of patients with nonalcoholic fatty liver disease

Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study

...

are the top articles of Ramazan Idilman at Ankara Üniversitesi.

What are Ramazan Idilman's research interests?

The research interests of Ramazan Idilman are: Hepatology

What is Ramazan Idilman's total number of citations?

Ramazan Idilman has 11,695 citations in total.